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The human microbiota consists of communities of microorganisms that inhabit the 43 human body. These communities can significantly affect many aspects of human 44 physiology. For example, in healthy individuals the microbiota provides a wide range of 45 metabolic functions that humans lack, making their presence advantageous (Gill et al., 46 2006; Sommer and Backhed, 2013) . In addition, altered microbiotas are associated with a 47 number of chronic inflammatory disorders including autoimmunity and allergic disorders 48 (Aas, Gessert and Bakken, 2003) , obesity and diabetes (Devaraj, Hemarajata and 49 Versalovic, 2013). One analytic goal of microbiota studies is to compare the bacterial 50 communities across groups. The human microbiome project endeavors to apply this to 51 human associated communities in order to identify bacteria that either adversely affect or 52 promote health (Group et al., 2009) . 53
Bacteria are generally identified using culturing methods, which assume prior knowledge 54 of the growth condition required for isolation. With the advent of DNA-based sequencing 55 technology, identification of organisms present in the community can now be performed 56 in parallel, which results in significant efficiency compared to culture. The process starts 57 with the collection of human-associated samples for DNA extraction. The DNA is used to 58 amplify 16S PCR gene sequences that are taxonomically informative, and data is 59 collected using next generation sequencing technologies. These data are compared to 60 reference databases to determine organism identity (taxonomic category). The number of 61 sequences for a single taxon is then counted for each sample for comparison within a 62 study. 63
Microbiota sequence data are high-dimensional with added complexity. They consist of 64 non-negative, highly skewed sequence counts with a large number of zeros. The number 65 of zeros in the dataset is a result of combining samples with different bacterial 66 composition (e.g. disease versus controls or different locations in one subject). Samples 67 collected from different groups can result in unique organisms, and if an organism is 68 detected in one but not another sample, insertion of a zero count is performed. The 69 absence of a count for an organism can be due to the fact that the organism simply isn't 70 present in the sample (true zeros) or that the organism is present but sufficiently rare such 71 that it does not appear in the sequence collection (false zeros). In addition, the number of 72 total sequences varies from sample to sample. This is a result of an inability to specify 73 exactly the number of sequences to be measured on a sample using currently available 74 technology. Note the number of sequences for a given sample is not associated with any 75 biological feature of the sample, and thus should have a random distribution across 76 samples. A common approach to account for the variation in the total number of 77 sequences, is the conversion of the sequence counts to relative abundance (taxon 78 counts/total counts) within a particular sample (Wagner, Robertson and Harris, 2011 The dataset is from a study in which pediatric individuals with normal esophageal 103 mucosa provided samples to capture esophageal microbiota. The different sample types 104 include the "gold standard" mucosal biopsy and the minimally invasive capsule-based 105 string collection, the Enterotest™ named Esophageal String Test in that study (EST). 106
Additionally, an oral string segment and nasal cavity swabs were collected for 107
comparison. All of the 15 subjects enrolled in this study had normal histological biopsy 108 findings. Most of the samples had adequate bacterial load for data generation, and only 109 two nasal swabs did not amplify (i.e., 13 nasal swabs and 15 oral strings, ESTs and 110 biopsies). Bacterial ribosomal RNA gene amplification products from mucosal biopsies 111 and from the nasal cavity, oral cavity and EST were produced and sequenced. Additional 112 details of the study and the data generation process have been previously published 113 (Fillon et al., 2012) . The aim of the study was to compare the esophageal microbiota 114 identified from biopsies and ESTs, and to show if there are highly similar profiles 115 between the EST and biopsy samples that were different from samples collected from the 116 nasal and oral cavity (Fillon et al., 2012 are two distinct data generation processes, which is determined with the use of a 127
Bernoulli trial. With probability π, the response of the first process is a zero count, and 128 with probability of (1-π) the response of the second process is governed by a negative 129 binomial with mean λ and can also generate zero counts. The overall probability of zero 130 counts is the combined probability of zeros from the two processes. Thus, a ZINB model 131 for the response Y can be written as: 132 An offset, the natural logarithm of the total sequence counts, log(Total ij ), was added into 145 the linear predictor function for the negative binomial component to account for the 146 variable number of sequences per sample inherent in microbiota sequence data. That is, 147
log (E(Y ij )) = X' ij + u i +log(Total ij ). This can be simplified to show that log (E(Y ij )/Total ij ) 148 = X' ij + u i . The left side of this equation is, therefore, modeling the log of the relative 149 abundance as the outcome, assuming the total sequence count is considered a fixed value 150 rather than a random variable. Note that the parameter π ij is not affected by the total 151 sequence count. 152
Here, u i and v i are the random intercepts and they are assumed to be independent and 153 follow the bivariate normal distribution as 154 The sigmas in Table 1 correspond to the estimated standard deviations for the normally 185 distributed random subject effects. The variances of the random effect for the zero-186 inflated part of the model, v i , was significant, indicating that the probability of a false 187 zero count was different among the subjects. The random effect variance for the count 188 distribution, u i , was also significant, meaning that some subjects had higher sequence 189 counts than others. Also, as a sensitivity analysis, a model that included correlation 190 between the random effects was estimated. This correlation was not significant, thus 191 providing evidence that the two processes (false zeros and the count process) are 192 independent. 193 Examination of the full dataset (187 taxa) yielded estimates for 86 taxa where the mixed 194 ZINB models successfully converged. However, the final Hessian matrix was not 195 positive definite for 64 of the models. For those models that could not be estimated, the 196 majority of the taxa had a large percentage of zero counts with either extremely small or 197 large non-zero counts. Comparisons across the sample types were similarly performed as 198 described above across all taxa. Manhattan plots, commonly used in genetic studies, were 199 used here to display the magnitude of the p-values for each comparison ordered by 200 taxonomy line, and color-coded by phylum. Organisms close together, within a phylum, 201 denote closer phylogenetic relationship. As shown in the Manhattan plots (Figure 2) The distributions of the microbial sequence counts are highly skewed, non-negative and 212
have a large proportion of zeros, for which commonly used statistical approaches may not 213 be appropriate. The large proportion of zeros is intrinsic to the creation of the dataset 214 rather than the data generating process itself, where the dataset contains sequence counts 215 for organisms that were observed in at least one sample, if a particular organism was not 216 observed in a sample it is given a zero value. Therefore, when comparing sequence 217 counts across groups with diverse communities, a large numbers of zero counts are 218 expected. Our working hypothesis is two underlying processes explain the absence of a 219 count for an organism (true and false zeros). 220
In this paper, the ZINB mixed model was described. This model is useful for analysis of 221 over-dispersed count data with an excess of zeros and repeated measures. This model 222 based approach can additionally be easily extended to include potential confounders as 223 covariates and to test association with continuous variables. The application of the ZINB 224 to the three selected organisms from the microbiota data demonstrated the usefulness of 225 this approach when applied to organisms of interest. However, given the complexity of 226 the model, we are not able to easily apply it to all organisms and it requires adaption and 227 guidelines for high-dimensional applications. The majority of models that did not 228 converge were due to an inability to estimate the relatively large number of parameters 229 with the available data. It is more likely that this model will address more focused 230 questions related to a small subset of organisms of clinical interest. 231
To assess the effects of misspecification of random effect distributions in the two parts of 232 ZINB regression model, other distributional assumptions apart from normality could be 233 considered in future research. In our study, we separately fit the models to the organisms 234 identified thus ignoring potential correlation among organisms. We are interested in 235 extending the modeling to pairs of organisms multivariately or implementation of a 236 multi-level (two-fold random effects) zero-inflated model. 237 238 239 5. Summery 240 241
We have illustrated the novel application of a ZINB model with random effects to a 242 microbiota dataset with a repeated measures design. The range of distributions present for 243 the individual taxa in a microbiota dataset additionally provides insight into when the use 244 of a zero-inflated approach is appropriate. 245 
